GlassScriptPhysician profile
Joseph P Orallo
NPI 1306379847
$22,255.74
in general payments reported to CMS, 2019-2025
56 companies · $4,480 in 2025
The $4,480 reported for 2025 was more than what 98% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,224 · 2022: $3,583 · 2023: $4,523 · 2024: $4,446 · 2025: $4,480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,448.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $4,100.32 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $2,360.20 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $2,255.73 | 2021-2025 | |
| Amgen INC. | $1,982.13 | 2021-2025 | Repatha, Repatha, Otezla |
| Glaxosmithkline, LLC. | $1,762.15 | 2021-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Biohaven Pharmaceuticals, INC. | $1,202.71 | 2021 | |
| Lilly USA, LLC | $1,168.95 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $804.83 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $738.92 | 2021-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $595.06 | 2021-2025 | Synjardy, Jardiance, Jascayd |
| Abbott Laboratories | $552.17 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Merck Sharp & Dohme LLC | $490.95 | 2021-2025 | Capvaxive, Gardasil 9, Steglatro |
| Phathom Pharmaceuticals, INC. | $422.82 | 2024-2025 | Voquezna |
| Vanda Pharmaceuticals INC. | $355.04 | 2024-2025 | Fanapt, Hetlioz |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $301.93 | 2024-2025 | Caplyta |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $282.42 | 2024-2025 | Auvelity, Sunosi |
| Exact Sciences Corporation | $233.42 | 2023-2025 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $220.63 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $205.02 | 2021-2025 | |
| Boston Scientific Corporation | $185.86 | 2023-2025 | Watchman Flx, Superion Indirect Decompression System |
| Biohaven Pharmaceutical Holding Company LTD. | $164.24 | 2022 | |
| Daiichi Sankyo INC. | $157.02 | 2021-2025 | Injectafer |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $155.56 | 2022-2025 | Xifaxan |
| Otsuka America Pharmaceutical, INC. | $147.51 | 2024-2025 | Rexulti |
| Abiomed | $130.50 | 2025 | |
| Imperative Care, INC | $109.24 | 2024 | Prodigy Catheter |
| Idorsia Pharmaceuticals US INC | $106.98 | 2022-2024 | Quviviq |
| Vivus LLC | $90.12 | 2021-2023 | Qsymia |
| Xeris Pharmaceuticals, INC. | $89.65 | 2022-2023 | Gvoke Hypopen |
| Bayer Healthcare Pharmaceuticals INC. | $76.15 | 2023-2025 | |
| Eisai INC. | $65.38 | 2021-2022 | |
| Esperion Therapeutics, INC. | $63.11 | 2021-2023 | Nexletol |
| Medtronic, INC. | $61.58 | 2022-2025 | Inceptiv, Intellis Adaptivestim |
| Radius Health, INC. | $59.26 | 2021-2024 | |
| Sanofi-Aventis U.S. LLC | $47.26 | 2021-2022 | |
| Sanofi Pasteur INC. | $40.97 | 2023 | |
| Cequr Corporation | $39.18 | 2024 | Cequr Simplicity |
| Hikma Pharmaceuticals USA | $35.23 | 2021-2022 | |
| Dynavax Technologies Corporation | $34.39 | 2023 | Heplisav-B |
| Clarus Therapeutics INC. | $34.10 | 2021 | |
| Neos Therapeutics, LP | $32.46 | 2022-2024 | Adzenys Xr-Odt |
| Sumitomo Pharma America, INC. | $31.55 | 2025 | Gemtesa |
| Antares Pharma, INC. | $30.01 | 2023 | Tlando, Xyosted, Nocdurna |
| Kowa Pharmaceuticals America, INC. | $28.48 | 2022 | |
| Dexcom, INC. | $26.83 | 2021-2023 | Dexcom G6 Transmitter |
| Genentech USA, INC. | $20.00 | 2021 | |
| Inspire Medical Systems, INC. | $18.68 | 2024 | Inspire |
| Cvrx, INC. | $18.64 | 2024 | Barostim Neo System |
| Endo Pharmaceuticals INC. | $17.74 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.81 | 2022 | |
| Almatica Pharma LLC | $16.07 | 2022 | |
| Eyevance Pharmaceuticals LLC | $15.84 | 2021 | |
| Jazz Pharmaceuticals INC. | $14.80 | 2021 | |
| Amneal Pharmaceuticals LLC | $13.36 | 2021 | |
| Ibsa Pharma INC. | $13.04 | 2023 | Tirosint, Licart |
| Arbor Pharmaceuticals, INC. | $12.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Orallo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.